Business
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026
Company to engage industry partners and distribution channels as part of expanding BioCosmeceutical commercialization strategy MELVILLE, N.Y., March 05, 2026
About this update from Biorestorative Therapies, Inc.
[{"type":"text","content":"Company to engage industry partners and distribution channels as part of expanding BioCosmeceutical commercialization strategy MELVILLE, N.Y., March 05, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a late stage clinical regenerative medicine innovator focused on stem cell-based therapies and products, today announced that members of its commercial leadership team will participate in the Be+Well Beauty and Wellness Show taking place March 8-10, 2026 at the Javits Center in New York City. The Be+Well trade show is one of the largest professional beauty, spa, and wellness trade events in the U.S., bringing together 35,000+ beauty and wellness professionals, 600+ exhibiting brands, and 180+ classes and interactive educational opportunities. BioRestorative will attend the event as part of its ongoing efforts to expand commercialization awareness and distribution opportunities for its BioCosmeceutical platform, which applies regenerative biologics technology to the rapidly evolving aesthetics and longevity markets. The event brings together leading companies, clinics, medspas, distributors, and wellness brands across the beauty, aesthetics, and professional skincare industries. Crystal Romano, Head of Global Commercial Operations, together with her team, will lead the Company’s engagement at the conference, meeting with potential business and marketing partners, distributors, and practitioners to discuss product adoption, marketing collaborations, and the expanded commercial deployment of the Company’s proprietary regenerative skincare technologies. “The Be+Well show provides an important opportunity to engage directly with industry stakeholders as we expand awareness of our BioCosmeceutical platform and highlight our unique approach, which intersects skincare, aesthetics, and regenerative medicine,” said Ms. Romano. “Our approach reflects BioRestorative’s broader regenerative medicine expertise, applying biologically active secretome components—including exosomes, growth factors, and signaling proteins—to products designed for professional aesthetics, medical-grade skincare environments, and at-home regenerative regimens. As we see in the market, clinics, medspas, and beauty and self-care venues are rapidly adopting these solutions, with exosome treatments now used...